Skip to content
10-K

Annual Report

Maravai LifeSciences Holdings, Inc. MRVI

0001823239-25-000034

← back to feed
Filed
Mar 18, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2024 · Sep 30, 2024 141.56M sh
Shares Diluted FY 2024 · Sep 30, 2024 136.6M sh
Shares Diluted FY 2024 · Jun 30, 2024 135.84M sh
Shares Diluted FY 2024 · Jun 30, 2024 134.09M sh
Shares Diluted FY 2024 · Dec 31, 2022 255.32M sh
Long Term Debt FY 2024 · Sep 30, 2024 $516.28M
Long Term Debt FY 2024 · Jun 30, 2024 $517.08M
Long Term Debt FY 2024 · Dec 31, 2023 $518.71M
Short Term Debt FY 2024 · Sep 30, 2024 $5.44M
Short Term Debt FY 2024 · Jun 30, 2024 $5.44M
Short Term Debt FY 2024 · Dec 31, 2023 $5.44M
Cash And Equivalents FY 2024 · Sep 30, 2024 $578.16M
Cash And Equivalents FY 2024 · Jun 30, 2024 $573.17M
Cash And Equivalents FY 2024 · Dec 31, 2023 $574.96M
Stockholders Equity FY 2024 · Sep 30, 2024 $344.9M
Stockholders Equity FY 2024 · Jun 30, 2024 $434.73M
Stockholders Equity FY 2024 · Dec 31, 2023 $416.75M
Current Liabilities FY 2024 · Sep 30, 2024 $63.71M
Current Liabilities FY 2024 · Jun 30, 2024 $68.62M
Current Liabilities FY 2024 · Dec 31, 2023 $87.47M
Total Liabilities FY 2024 · Sep 30, 2024 $665.56M
Total Liabilities FY 2024 · Jun 30, 2024 $671.26M
Total Liabilities FY 2024 · Dec 31, 2023 $697.57M
Current Assets FY 2024 · Sep 30, 2024 $679.14M
Current Assets FY 2024 · Jun 30, 2024 $681.5M
Current Assets FY 2024 · Dec 31, 2023 $699.91M
Total Assets FY 2024 · Sep 30, 2024 $1.28B
Total Assets FY 2024 · Jun 30, 2024 $1.44B
Total Assets FY 2024 · Dec 31, 2023 $1.49B
Eps Diluted FY 2024 · Sep 30, 2024 −$0.68
Eps Diluted FY 2024 · Sep 30, 2024 −$0.87
Eps Diluted FY 2024 · Jun 30, 2024 −$0.07
Eps Diluted FY 2024 · Jun 30, 2024 −$0.16
Eps Diluted FY 2024 · Dec 31, 2022 $1.67
Eps Basic FY 2024 · Sep 30, 2024 −$0.68
Eps Basic FY 2024 · Sep 30, 2024 −$0.87
Eps Basic FY 2024 · Jun 30, 2024 −$0.07
Eps Basic FY 2024 · Jun 30, 2024 −$0.16
Eps Basic FY 2024 · Dec 31, 2022 $1.67
Sga Expense FY 2024 · Sep 30, 2024 $39.09M
Sga Expense FY 2024 · Sep 30, 2024 $120.53M
Sga Expense FY 2024 · Jun 30, 2024 $40.56M
Sga Expense FY 2024 · Jun 30, 2024 $81.44M
Sga Expense FY 2024 · Dec 31, 2022 $129.26M
Rd Expense FY 2024 · Sep 30, 2024 $4.7M
Rd Expense FY 2024 · Sep 30, 2024 $14.66M
Rd Expense FY 2024 · Jun 30, 2024 $4.92M
Rd Expense FY 2024 · Jun 30, 2024 $9.96M
Rd Expense FY 2024 · Dec 31, 2022 $18.37M
Net Income FY 2024 · Sep 30, 2024 −$97.07M
Net Income FY 2024 · Sep 30, 2024 −$118.94M
Net Income FY 2024 · Jun 30, 2024 −$9.79M
Net Income FY 2024 · Jun 30, 2024 −$21.87M
Net Income FY 2024 · Dec 31, 2022 $220.21M
Operating Income FY 2024 · Sep 30, 2024 −$165.61M
Operating Income FY 2024 · Sep 30, 2024 −$197.92M
Operating Income FY 2024 · Jun 30, 2024 −$13.44M
Operating Income FY 2024 · Jun 30, 2024 −$32.3M
Operating Income FY 2024 · Dec 31, 2022 $574.22M
Cost Of Revenue FY 2024 · Sep 30, 2024 $36.79M
Cost Of Revenue FY 2024 · Sep 30, 2024 $113.71M
Cost Of Revenue FY 2024 · Jun 30, 2024 $38.58M
Cost Of Revenue FY 2024 · Jun 30, 2024 $76.92M
Cost Of Revenue FY 2024 · Dec 31, 2022 $168.96M
Revenue FY 2024 · Sep 30, 2024 $69.03M
Revenue FY 2024 · Sep 30, 2024 $202.63M
Revenue FY 2024 · Jun 30, 2024 $69.42M
Revenue FY 2024 · Jun 30, 2024 $133.6M
Revenue FY 2024 · Dec 31, 2022 $883M
Capex FY 2024 · Dec 31, 2022 $17.09M
Operating Cash Flow FY 2024 · Dec 31, 2022 $535.98M